The Central Drugs Standard Control Organisation (CDSCO) has informed the World Health Organisation (WHO) that three cough syrups — Coldrif, Respifresh TR, and ReLife — have been recalled and their production has been stopped. The regulator has also clarified that none of these products were exported from India, as per a report by news agency PTI.

The WHO had reached out to Indian authorities after media reports from Madhya Pradesh and Rajasthan described clusters of child deaths and illnesses showing symptoms such as acute renal failure and acute encephalitis syndrome. The illnesses were suspected to be associated with certain oral syrup medicines. The WHO wanted to ascertain whether the cough syrups allegedly linked to children’s deaths were exported to other countries.

The global healt

See Full Page